CNO (CNO) President Karen DeToro Exercises Options and Sells Shares

What Happened

• Karen J. DeToro, President, Worksite Division of CNO Financial Group (CNO), exercised stock options and sold common shares over Aug 31–Sep 2, 2026. She exercised two tranches of 7,500 options (15,000 total) at a $15.83 strike (cost $237,450) and reported multiple open-market sales totaling 24,674 shares for aggregate gross proceeds of about $1,355,098.
• There are also two "exercise/conversion" entries recorded at $0.00 for 7,500 shares each (reported as disposed) — see the filing for the nature of these derivative conversions. Many of the sales were executed under a Rule 10b5-1 trading plan.

Key Details

• Transaction dates and prices:
  • 2026-08-31: Exercised 7,500 options @ $15.83 (acquired; $118,725); sold 1,874 shares @ $54.98 (≈$103,033) and 7,500 shares @ $54.98 (≈$412,333).
  • 2026-09-01: Exercised 7,500 options @ $15.83 (acquired; $118,725); sold 1,836 shares @ $54.73 (≈$100,484) and 7,500 shares @ $54.74 (≈$410,519).
  • 2026-09-02: Sold 5,964 shares @ $55.12 (≈$328,729).
  • Two additional entries (8/31 and 9/1) show exercise/conversion of 7,500 shares each at $0.00 reported as dispositions (see filing).
• Gross proceeds from the visible open-market sales: ≈$1.355M. Cost to exercise listed options: $237,450.
• Sales price notes: filing provides weighted-average sale prices and ranges (per footnotes F2–F5); reporter will provide per-price breakdown on request.
• Some sales were made under a Rule 10b5-1 plan adopted May 11, 2026 (footnote F1).
• Vesting note: related options had vested in two halves on 9/30/2021 and 9/30/2022 (footnote F6).
• Shares owned after the transactions are not provided in the summary data here — see the full Form 4 for post-transaction holdings.
• Filing date: 2026-09-02. No late-filing flag was provided in the supplied data.

Context

• The activity combines option exercises (acquisitions) with near-immediate open-market sales — a common pattern when insiders exercise options and sell some or all shares (often to cover exercise cost/taxes or as planned disposition). The two derivative entries recorded at $0.00 should be reviewed on the Form 4 for whether they represent net settlements, conversions, or other non-cash dispositions.
• Sales made under a 10b5-1 plan are pre-arranged trading plans and typically indicate pre-scheduled disposals rather than discretionary timing by the insider. This summary is factual only and does not infer motivations. For full details and any ownership totals, consult the complete Form 4 (Accession 0001789577-26-000011).